Technical Analysis for MRUS - Merus N.V.

Grade Last Price % Change Price Change
C 44.32 0.96% 0.42
MRUS closed up 0.96 percent on Monday, March 18, 2024, on 1.24 times normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
3 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Down

Date Alert Name Type % Chg
Oversold Stochastic Weakness 0.00%
New Downtrend Bearish 0.96%
Down 3 Days in a Row Weakness 0.96%
Down 4 Days in a Row Weakness 0.96%
Oversold Stochastic Weakness 0.96%
NR7 Range Contraction -0.63%
Stochastic Reached Oversold Weakness -0.63%
Down 3 Days in a Row Weakness -0.63%
Oversold Stochastic Weakness -0.63%
1,2,3 Pullback Bullish Bullish Swing Setup -2.21%

   Recent Intraday Alerts

Alert Time
Up 3% about 9 hours ago
Rose Above Previous Day's High about 11 hours ago
60 Minute Opening Range Breakout about 11 hours ago
Up 2% about 11 hours ago
Up 1% about 11 hours ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Merus N.V. Description

Merus B.V., a clinical-stage immuno-oncology company, engages in developing bispecific antibody therapeutics. Its lead bispecific antibody candidate is MCLA-128, which is in Phase I/II clinical trials in Europe for the treatment of various solid tumors, including breast, colorectal, and ovarian cancers. The company also develops MCLA-117, a bispecific antibody candidate that is expected to commence a Phase I/II clinical trial for the treatment of patients with acute myeloid leukemia, as well as for the treatment of myelodysplastic syndrome in pre-clinical studies. Its pre-clinical bispecific antibody candidates include MCLA-134, MCLA-114, and MCLA-145, as well as other early research projects. The company has a strategic collaboration with Gustave Roussy to develop innovative bispecific antibodies for therapeutic immuno-oncology applications. Merus B.V. was founded in 2003 and is headquartered in Utrecht, the Netherlands.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Immunology Solid Tumors Antibodies Cancer Immunotherapy Monoclonal Antibodies Acute Myeloid Leukemia Ovarian Cancer Myelodysplastic Syndrome Monoclonal Antibody Therapy Oncology Applications Novimmune Treatment Of Myelodysplastic Syndrome

Is MRUS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Comments

S

SwingScalp about 1 year ago

This is the only Expansion Breakout scan symbol for March 15th.  Looks interesting to me so might take this setup today.

0 Reply
T

TraderMike about 1 year ago

I hope it goes well

0 Reply
S

SwingScalp about 1 year ago

I added several Expansion Pivot Buy scan result symbols from the 15th to my daytrade charts in my broker platform as well.  Thanks.  ROL VERX and TIMB look interesting.

0 Reply
S

SwingScalp about 1 year ago

I should have written the only Bullish - Expansion Breakout scan symbol.

0 Reply

View full discussion...

Indicators

Indicator Value
52 Week High 52.035
52 Week Low 17.16
Average Volume 609,933
200-Day Moving Average 28.17
50-Day Moving Average 40.50
20-Day Moving Average 47.22
10-Day Moving Average 46.42
Average True Range 2.10
RSI (14) 48.98
ADX 45.26
+DI 17.12
-DI 17.32
Chandelier Exit (Long, 3 ATRs) 45.73
Chandelier Exit (Short, 3 ATRs) 47.50
Upper Bollinger Bands 51.42
Lower Bollinger Band 43.02
Percent B (%b) 0.16
BandWidth 17.80
MACD Line 1.19
MACD Signal Line 2.25
MACD Histogram -1.0648
Fundamentals Value
Market Cap 2.56 Billion
Num Shares 57.7 Million
EPS -3.72
Price-to-Earnings (P/E) Ratio -11.91
Price-to-Sales 52.88
Price-to-Book 6.02
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 46.39
Resistance 3 (R3) 46.47 45.85 46.05
Resistance 2 (R2) 45.85 45.33 45.82 45.93
Resistance 1 (R1) 45.09 45.00 44.78 45.01 45.81
Pivot Point 44.47 44.47 44.32 44.44 44.47
Support 1 (S1) 43.71 43.95 43.40 43.63 42.83
Support 2 (S2) 43.09 43.62 43.06 42.71
Support 3 (S3) 42.33 43.09 42.60
Support 4 (S4) 42.25